End-of-day quote
Shenzhen S.E.
06:00:00 2024-04-25 pm EDT
|
5-day change
|
1st Jan Change
|
6.48
CNY
|
+0.62%
|
|
-0.61%
|
-18.70%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
3,966
|
4,735
|
4,880
|
3,446
|
2,889
|
2,349
|
-
|
Enterprise Value (EV)
1 |
3,966
|
4,735
|
4,880
|
3,446
|
2,889
|
2,349
|
2,349
|
P/E ratio
|
11.7
x
|
12.1
x
|
15.1
x
|
17.3
x
|
46.9
x
|
8.76
x
|
7.36
x
|
Yield
|
-
|
-
|
-
|
2.67%
|
-
|
-
|
-
|
Capitalization / Revenue
|
1.4
x
|
1.08
x
|
-
|
0.69
x
|
0.68
x
|
0.41
x
|
0.39
x
|
EV / Revenue
|
1.4
x
|
1.08
x
|
-
|
0.69
x
|
0.68
x
|
0.41
x
|
0.39
x
|
EV / EBITDA
|
-
|
6.73
x
|
-
|
-
|
6.98
x
|
3.18
x
|
2.94
x
|
EV / FCF
|
-
|
-
|
-
|
-37,650,580
x
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-0%
|
-
|
-
|
-
|
Price to Book
|
1.91
x
|
2
x
|
-
|
1.33
x
|
1.13
x
|
0.77
x
|
0.71
x
|
Nbr of stocks (in thousands)
|
372,525
|
372,525
|
372,534
|
368,206
|
362,498
|
362,498
|
-
|
Reference price
2 |
10.65
|
12.71
|
13.10
|
9.360
|
7.970
|
6.480
|
6.480
|
Announcement Date
|
2/27/20
|
4/19/21
|
4/19/22
|
4/19/23
|
4/25/24
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
2,833
|
4,388
|
-
|
5,016
|
4,224
|
5,794
|
5,995
|
EBITDA
1 |
-
|
703.3
|
-
|
-
|
414.2
|
739
|
799
|
EBIT
1 |
354.3
|
493.8
|
-
|
258.6
|
64.29
|
324
|
383
|
Operating Margin
|
12.51%
|
11.25%
|
-
|
5.16%
|
1.52%
|
5.59%
|
6.39%
|
Earnings before Tax (EBT)
1 |
365.6
|
490.5
|
-
|
255.3
|
64.33
|
321
|
380
|
Net income
1 |
321.9
|
386
|
306.9
|
219
|
62.05
|
275
|
326
|
Net margin
|
11.36%
|
8.8%
|
-
|
4.37%
|
1.47%
|
4.75%
|
5.44%
|
EPS
2 |
0.9077
|
1.050
|
0.8700
|
0.5400
|
0.1700
|
0.7400
|
0.8800
|
Free Cash Flow
|
-
|
-
|
-
|
-91.54
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-1.82%
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
0.2500
|
-
|
-
|
-
|
Announcement Date
|
2/27/20
|
4/19/21
|
4/19/22
|
4/19/23
|
4/25/24
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-91.5
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
17.4%
|
17.5%
|
-
|
8.01%
|
2.23%
|
3.8%
|
4.3%
|
ROA (Net income/ Total Assets)
|
-
|
7.75%
|
-
|
-
|
-
|
8.7%
|
9.6%
|
Assets
1 |
-
|
4,978
|
-
|
-
|
-
|
3,161
|
3,396
|
Book Value Per Share
2 |
5.560
|
6.360
|
-
|
7.060
|
7.080
|
8.460
|
9.080
|
Cash Flow per Share
|
-
|
2.420
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
373
|
348
|
-
|
734
|
235
|
135
|
142
|
Capex / Sales
|
13.16%
|
7.93%
|
-
|
14.63%
|
5.57%
|
2.33%
|
2.37%
|
Announcement Date
|
2/27/20
|
4/19/21
|
4/19/22
|
4/19/23
|
4/25/24
|
-
|
-
|
Last Close Price
6.48
CNY Average target price
10
CNY Spread / Average Target +54.32% Consensus |
1st Jan change
|
Capi.
|
---|
| -18.70% | 324M | | +1.19% | 3.58B | | -17.77% | 2.21B | | -13.26% | 1.85B | | -0.69% | 1.8B | | -5.70% | 1.6B | | +0.77% | 1.27B | | -2.91% | 1.1B | | -22.97% | 1.02B | | -8.05% | 951M |
Pesticide
|